CYP1A1 and breast carcinoma: It has been published that via preventing PTEN and stimulating β-Catenin and Akt pathways, the AhR/CYP1A1 signaling pathway affected the phenotypes of breast cancer stem cells, such as growth, development, renewal, and chemoresistance (Al-Dhfyan et al., 2017).